Beleave Stock Cash And Equivalents
Beleave fundamentals help investors to digest information that contributes to Beleave's financial success or failures. It also enables traders to predict the movement of Beleave Pink Sheet. The fundamental analysis module provides a way to measure Beleave's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Beleave pink sheet.
Beleave |
Beleave Company Cash And Equivalents Analysis
Beleave's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current Beleave Cash And Equivalents | 120.41 K |
Most of Beleave's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Beleave is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
CompetitionIn accordance with the recently published financial statements, Beleave has 120.41 K in Cash And Equivalents. This is 99.99% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The cash and equivalents for all United States stocks is 100.0% higher than that of the company.
Beleave Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Beleave's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Beleave could also be used in its relative valuation, which is a method of valuing Beleave by comparing valuation metrics of similar companies.Beleave is currently under evaluation in cash and equivalents category among its peers.
Beleave Fundamentals
| Return On Equity | -1.27 | |||
| Return On Asset | -0.25 | |||
| Operating Margin | (3.87) % | |||
| Current Valuation | 5.66 K | |||
| Shares Outstanding | 566.37 M | |||
| Price To Earning | (4.44) X | |||
| Price To Book | 0 X | |||
| Price To Sales | 0.0002 X | |||
| Revenue | 2.37 M | |||
| Gross Profit | 816.46 K | |||
| EBITDA | (30.76 M) | |||
| Net Income | (33.78 M) | |||
| Cash And Equivalents | 120.41 K | |||
| Debt To Equity | 2.44 % | |||
| Current Ratio | 0.16 X | |||
| Book Value Per Share | 0.01 X | |||
| Cash Flow From Operations | (9.47 M) | |||
| Earnings Per Share | (0.03) X | |||
| Beta | 27.8 | |||
| Market Capitalization | 566 | |||
| Total Asset | 23.61 M | |||
| Z Score | -3.3 | |||
| Net Asset | 23.61 M |
About Beleave Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Beleave's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Beleave using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Beleave based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Beleave Pink Sheet
If you are still planning to invest in Beleave check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Beleave's history and understand the potential risks before investing.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |